Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bolt Biotherapeutics, Inc.

NASDAQ: BOLT · Life Sciences · 8 alerts · CIK 1641281

Share price
$5.80Close, Nov 16
Market cap
$15.1M
Shares outstanding
2.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bolt Biotherapeutics, Inc. filings on SEC EDGAR ↗

6:05 PM ET Form 4
Insider Selling

Bolt Biotherapeutics COO Grant Yonehiro Sells $38.5K of Stock

Grant Yonehiro, COO, sold 11,759 shares of Bolt Biotherapeutics, Inc. at $3.24 to $3.32 a share (average $3.27) in 2 transactions, worth $38.5K in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 17,269 (-28.4%).

Value
$38.5K
Shares
11,759
Average price
$3.27
Role
COO
Holding change
-28.4%
Trade date
Sep 17, 2026 to Sep 18, 2026
6:05 PM ET Form 4
Insider Selling

Bolt Biotherapeutics Senior VP, Finance and PAO Sarah Nemec Sells $13.2K of Stock

Sarah Nemec, Senior VP, Finance and PAO, sold 4,077 shares of Bolt Biotherapeutics, Inc. at $3.24 a share, worth $13.2K in total on Sep 18, 2026. Shares held after the trade: 17,082 (-19.3%).

Value
$13.2K
Shares
4,077
Price
$3.24
Role
Senior VP, Finance and PAO
Holding change
-19.3%
Trade date
Sep 18, 2026
6:04 PM ET Form 4
Insider Selling

Bolt Biotherapeutics President, CEO and CFO William P. Quinn Sells $51.3K of Stock

William P. Quinn, President, CEO and CFO, sold 15,677 shares of Bolt Biotherapeutics, Inc. at $3.24 to $3.32 a share (average $3.27) in 2 transactions, worth $51.3K in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 25,384 (-26.5%).

Value
$51.3K
Shares
15,677
Average price
$3.27
Role
President, CEO and CFO
Holding change
-26.5%
Trade date
Sep 17, 2026 to Sep 18, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.